avarol has been researched along with Adenocarcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Filimonov, A; Filimonova, M; Grozdanic, N; Ivanov, S; Kaprin, A; Nikitovic, M; Petovic, S; Shegay, P; Shitova, A; Soldatova, O; Stanojkovic, TP; Vladic, J | 1 |
1 other study(ies) available for avarol and Adenocarcinoma
| Article | Year |
|---|---|
Evaluation of In Vitro Cytotoxic Potential of Avarol towards Human Cancer Cell Lines and In Vivo Antitumor Activity in Solid Tumor Models.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Cell Line; Colonic Neoplasms; Humans; Hydroquinones; Lung Neoplasms; Mice; Sesquiterpenes | 2022 |